Update: June 5th, 2025 Author: Eric Patterson, LPC (No change) Medical Reviewer: Benjamin Troy, MD (No change) Primary Changes: Edited for clarity and accuracy
Accessibility : Small, user-friendly anytime and anywhere
For example, potential effects on alcohol dependency are supported by a recent real-world population propensity-score-matched study of 83,825 patients with obesity, which showed that semaglutide, compared with other non-GLP-1-based obesity medications, was associated with a 50% lower risk for incident and recurrent alcohol use disorders over a 12-month period regardless of T2D status 24
Hers GLP-1 Weight Loss for Women (2026): Program Overview, Medication Options, Pricing, and Safety In Brief: Weight Loss by Hers offers a telehealth pathway where a licensed clinician may prescribe GLP-1 or other weight-management medications based on individual eligibility
The risk was generally low and was consistent for all groups
Erickson M, Banks W